Universe Pharmaceuticals (UPC) Assets Average (2021 - 2025)

Universe Pharmaceuticals has disclosed Assets Average across 5 years of filings, most recently posting $68.6 billion for Q3 2025.

• Assets Average for Q3 2025 came in at $68.6 billion, up 101.84% year-over-year; the trailing twelve-month figure through Sep 2025 was $68.6 billion (up 101.84% YoY), and the FY2025 annual result was $68.6 billion, up 101.86% from the prior year.
• Assets Average came in at $68.6 billion for Q3 2025 at Universe Pharmaceuticals, up from $34.0 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $68.6 billion in Q3 2025 to a low of $35.1 million in Q3 2021.
• The 5-year median for Assets Average is $65.2 million (2022), against an average of $12.9 billion.
• Peak annual rise in Assets Average reached 60566.53% in 2024, while the deepest fall reached 29.83% in 2024.
• Universe Pharmaceuticals' Assets Average stood at $35.1 million in 2021, then jumped by 86.62% to $65.5 million in 2022, then fell by 14.37% to $56.0 million in 2023, then jumped by 60566.53% to $34.0 billion in 2024, then surged by 101.84% to $68.6 billion in 2025.
• The last three Assets Average figures came in at $68.6 billion (Q3 2025), $34.0 billion (Q3 2024), and $45.6 million (Q1 2024), per Business Quant data.